TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2024-11-13
公報種別公開国際商標公報
国際登録番号1809806
国際登録日2024-06-03
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Biological preparations for gene therapy; adeno-associated virus (aav) gene therapy preparations and pharmaceuticals; biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; drug delivery agents comprising capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics.,Pharmaceutical research and development in the field of gene therapy; pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of rna-derived functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery.,Medical treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies, namely, Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, tauopathies, synucleinopathies, and neurodegenerative disease.
基礎出願番号90879826
基礎出願日2021-08-12
基礎出願国US
出願人Voyager Therapeutics, Inc.
OCRテキストVOYAGEK
OCRテキスト2VOYAGER
OCRについて
この商標をJ-PlatPat（特許庁公式サイト）で参照する

関連商標

GlaxoSmithKline Biologicals S.A.
FLUVIXGO
1か月前
Biohaven Therapeutics Ltd.
KAYBELA
4か月前
GlaxoSmithKline Biologicals S.A.
RIXFLUGO
2か月前
GlaxoSmithKline Biologicals S.A.
EXFLUNA
2か月前
Aston Group Worldwide Ltd
INESSA
4か月前
Huang, Ke
Huang Lab
3か月前
Huang, Ke
Huang Lab Smarter Therapeutic Delivery
3か月前
Made By Brave Limited
TRUE OMEGAS+
24日前
Made By Brave Limited
TRUE ASHVWAGANDHA
24日前
Biohaven Therapeutics Ltd.
KREJUTRIA
4か月前
GlaxoSmithKline Biologicals S.A.
FLUVIXVY
1か月前
Precision Hydration Limited
PRECISION FUEL & HYDRATION
1か月前
Made By Brave Limited
ANCIENT + BRAVE
4か月前
AliveDx Suisse SA
ALIVEDX
24日前
MAFRA GROUP S.r.l.
4か月前
個人
COOPER
3日前
Gilead Sciences Ireland UC
ノ/IPEKDIO
1か月前
Gilead Sciences Ireland UC
ノ/IMUNESO
1か月前
ACROSS CO., LTD
Revolax
1か月前
PRG S & Tech Inc.
ROZELCRA
1か月前
Saraya USA, Inc.
KYHV
1か月前
Gilead Sciences Ireland UC
TIVDOMIO
1か月前
PRG S & Tech Inc.
GERYDA
1か月前
NOVARTIS AG
1か月前
Jiva Institue of Vedic Science & Culture
AYURVEDA
1か月前
NOVARTIS AG
1か月前
Spur Therapeutics Limited
(て U
1か月前
Synox Therapeutics UK Limited
YOJEMTU
1か月前
Gilead Sciences Ireland UC
/IMVIGRI
1か月前
Gilead Sciences Ireland UC
DOMTIGTA
1か月前
Gilead Sciences Ireland UC
PALDOMSA
1か月前
Gilead Sciences Ireland UC
DOMNUGO
1か月前
Boehringer Ingelheim International GmbH
1か月前
PARTNERCO HOLDINGS LLC
ABVANTAGE HIP WAIST REDUCER
1か月前
Lemme Inc.
PUKRK
1か月前
Gilead Sciences Ireland UC
っIG/ZIMIO
1か月前
続きを見る